Champions Oncology, Inc.
CSBR
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care basā¦ read more
Healthcare
Biotechnology
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.79
Price+0.61%
$0.04
1Y
Price
Market Cap
$93.333m
Small
Price/Earnings 3y Avg5y Avg
40x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+4.1%
EBITDA Margin+2.0%
Net Profit Margin-13.1%
Free Cash Flow Margin+4.1%
EBITDA Margin+2.0%
Net Profit Margin-13.1%
Free Cash Flow MarginRevenue
$58.424m
+2.6%
1y CAGR+3.1%
3y CAGR+4.7%
5y CAGREarnings
$2.524m
-46.3%
1y CAGR+27.3%
3y CAGR-247.9%
5y CAGREPS
$0.17
-48.5%
1y CAGR+24.7%
3y CAGR-250.2%
5y CAGRBook Value
$4.231m
$30.162m
Assets$25.931m
Liabilities$5.269m
DebtDebt to Assets
17.5%
1.4x
Debt to EBITDAFree Cash Flow
$5.640m
-19.4%
1y CAGR-187.6%
3y CAGR-159.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company